Panacea VC is a Dubai-based private-markets investment boutique founded by Pradeep Datwani, providing qualified investors with deal-by-deal access to late-stage private companies through dedicated special purpose vehicles. It is not a fund.
Panacea VC sources allocations in late-stage private companies, principally through secondary transactions and structured access ahead of a liquidity event. Each opportunity is structured as its own vehicle, so investors choose the companies they take exposure to rather than committing blind capital to a pool. Every opportunity is underwritten across the sponsor, the business, the entry point and the route to liquidity before it is presented to anyone.
The firm is based in Dubai and invests primarily in the United States, with selective exposure across Asia and Europe. It has operated since 2022. Typical transaction size is US$1 to 20 million.
The firm’s name is Panacea VC. Some earlier documents refer to Panacea Capital. It is not affiliated with Panacea Venture, the Shanghai and Silicon Valley life-sciences venture firm; with Panacea Biotec, the Indian pharmaceutical company; with Panacea Financial; or with any medical clinic carrying the name. Enquiries intended for those organisations should be directed to them.
Pradeep Datwani is a venture investor, entrepreneur and strategic advisor whose career spans more than two decades at the intersection of global capital markets and entrepreneurial value creation across Asia, Europe and the Middle East. Educated at Taipei American School and then in the United States, where he studied finance, he developed an early command of financial analysis and investment principles, together with a cross-cultural fluency that has defined his approach to global investing since.
He spent close to 25 years building his career across Hong Kong and Mumbai, working closely with entrepreneurs, private businesses and capital markets through periods of significant regional growth. He later relocated to London, where for more than seven years he deepened his expertise in venture capital and institutional investment. For the past four years he has been based in Dubai, working with founders, investors and high-growth businesses across multiple geographies.
His approach is built on disciplined opportunity selection and a long-term orientation toward value creation, evaluating businesses through an integrated financial, strategic and operational lens: market opportunity, business-model scalability, quality of management, competitive positioning, capital efficiency and risk, weighed with equal rigour.
His research notes are published in full. LinkedIn: pradeep-datwani.
General Partner of Anomaly Ventures, with board advisory roles at Johns Hopkins Medicine’s Department of Biomedical Engineering and the University of California, Irvine.
We seek to work with regulated General Partners and counterparties operating within applicable US, UK and European regulatory frameworks.
We conduct verification of the source of shares, transaction documentation and relevant ownership information.
Investors and transactions are subject to applicable know-your-customer and anti-money-laundering procedures.
Each investment is structured through a dedicated vehicle appropriate to the underlying transaction.
The investment structure is designed to maintain clear ownership and liability boundaries.
Transaction documentation and investor records are maintained through the relevant administrative and legal framework.
Material actions are subject to the applicable governance provisions of the investment structure and transaction documents.
Panacea VC works with a select group of qualified investors. If you would like to learn more and receive information on relevant investment opportunities, we invite you to get in touch.
Request an introductionOpportunities are offered selectively and subject to applicable eligibility requirements, jurisdictional restrictions and transaction-specific terms. Private-market investments involve illiquidity, valuation uncertainty and the potential loss of invested capital. Nothing on this page is investment advice or an offer of securities.